BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37832963)

  • 21. Novel Genetic Risk Variants and Clinical Predictors Associated With Primary Sclerosing Cholangitis in Patients With Ulcerative Colitis.
    Wang MH; Friton JJ; Rebert N; Monroe K; Nix BD; Fiocchi C; Raffals LE; Leighton JA; Pasha SF; Picco MF; Newberry RD; Achkar JP; Faubion WA
    Clin Transl Gastroenterol; 2023 Sep; 14(9):e00615. PubMed ID: 37440754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-Proteinase 3 Antibodies as a Biomarker for Ulcerative Colitis and Primary Sclerosing Cholangitis in Children.
    Laass MW; Ziesmann J; de Laffolie J; Röber N; Conrad K
    J Pediatr Gastroenterol Nutr; 2022 Apr; 74(4):463-470. PubMed ID: 35703948
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical aspects and prognosis of patients with inflammatory bowel disease associated with autoimmune liver diseases.
    Rocha HC; Vilela EG
    Gastroenterol Hepatol; 2022 Feb; 45(2):83-90. PubMed ID: 34023469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Th1 and Innate Lymphoid Cells Accumulate in Primary Sclerosing Cholangitis-associated Inflammatory Bowel Disease.
    Gwela A; Siddhanathi P; Chapman RW; Travis S; Powrie F; Arancibia-Cárcamo CV; Geremia A
    J Crohns Colitis; 2017 Sep; 11(9):1124-1134. PubMed ID: 28383652
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic Profiling of Colorectal Carcinomas of Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Disease.
    de Krijger M; Carvalho B; Rausch C; Bolijn AS; Delis-van Diemen PM; Tijssen M; van Engeland M; Mostafavi N; Bogie RMM; Dekker E; Masclee AAM; Verheij J; Meijer GA; Ponsioen CY
    Inflamm Bowel Dis; 2022 Sep; 28(9):1309-1320. PubMed ID: 35554535
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inflammatory bowel disease with primary sclerosing cholangitis: A Danish population-based cohort study 1977-2011.
    Sørensen JØ; Nielsen OH; Andersson M; Ainsworth MA; Ytting H; Bélard E; Jess T
    Liver Int; 2018 Mar; 38(3):532-541. PubMed ID: 28796371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PSC-IBD: specific phenotype of inflammatory bowel disease associated with primary sclerosing cholangitis.
    Bajer L; Wohl P; Drastich P
    Vnitr Lek; 2018; 64(6):659-664. PubMed ID: 30223664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inflammatory bowel disease of primary sclerosing cholangitis: a distinct entity?
    Nakazawa T; Naitoh I; Hayashi K; Sano H; Miyabe K; Shimizu S; Joh T
    World J Gastroenterol; 2014 Mar; 20(12):3245-54. PubMed ID: 24696608
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of the Clinical Course of Primary Sclerosing Cholangitis in Paediatric Population-Single Center Study.
    Wiecek S; Wojtyniak A; Pindur B; Machnikowska-Sokołowska M; Gruszczyńska K; Grzybowska-Chlebowczyk U
    Medicina (Kaunas); 2021 Jun; 57(7):. PubMed ID: 34199130
    [No Abstract]   [Full Text] [Related]  

  • 30. Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis.
    de Vries AB; Janse M; Blokzijl H; Weersma RK
    World J Gastroenterol; 2015 Feb; 21(6):1956-71. PubMed ID: 25684965
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors associated with major radiological progression of primary sclerosing cholangitis in patients with inflammatory bowel disease.
    Azzam N; AlRuthia Y; Alharbi O; Aljebreen A; Almadi M; Loftus EV
    Hepatol Int; 2020 Dec; 14(6):1114-1124. PubMed ID: 33369708
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary sclerosing cholangitis and its relationship to the colon in a black cohort of inflammatory bowel disease patients.
    Koczka CP; Geraldino-Pardilla LB; Lawlor G
    J Clin Gastroenterol; 2014 Feb; 48(2):e19-21. PubMed ID: 24402121
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Symptoms Do Not Correlate With Findings From Colonoscopy in Children With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis.
    Ricciuto A; Fish J; Carman N; Walters TD; Church PC; Hansen BE; Crowley E; Siddiqui I; Nguyen GC; Kamath BM; Griffiths AM
    Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1098-1105.e1. PubMed ID: 29378308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. AGPAT1 as a Novel Colonic Biomarker for Discriminating Between Ulcerative Colitis With and Without Primary Sclerosing Cholangitis.
    Vessby J; Wisniewski JR; Lindskog C; Eriksson N; Gabrysch K; Zettl K; Wanders A; Carlson M; Rorsman F; Åberg M
    Clin Transl Gastroenterol; 2022 May; 13(5):e00486. PubMed ID: 35363634
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High Risk of Advanced Colorectal Neoplasia in Patients With Primary Sclerosing Cholangitis Associated With Inflammatory Bowel Disease.
    Shah SC; Ten Hove JR; Castaneda D; Palmela C; Mooiweer E; Colombel JF; Harpaz N; Ullman TA; van Bodegraven AA; Jansen JM; Mahmmod N; van der Meulen-de Jong AE; Ponsioen CY; van der Woude CJ; Oldenburg B; Itzkowitz SH; Torres J
    Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1106-1113.e3. PubMed ID: 29378311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship of inflammatory bowel disease and primary sclerosing cholangitis.
    Fausa O; Schrumpf E; Elgjo K
    Semin Liver Dis; 1991 Feb; 11(1):31-9. PubMed ID: 2047887
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subclinical time span of inflammatory bowel disease in patients with primary sclerosing cholangitis.
    Broomé U; Löfberg R; Lundqvist K; Veress B
    Dis Colon Rectum; 1995 Dec; 38(12):1301-5. PubMed ID: 7497843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [CLINICAL AND MORPHOLOGICAL CHARACTERISTICS OF INTESTINAL LESIONS IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS].
    Pazenco EV; Karev VE; Raikhelson KL; Shchukina OB; Botina AV; Kharitonov AG; Semenov NV
    Eksp Klin Gastroenterol; 2016; (7):18-24. PubMed ID: 30284417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical characteristics of inflammatory bowel disease associated with primary sclerosing cholangitis.
    Sano H; Nakazawa T; Ando T; Hayashi K; Naitoh I; Okumura F; Miyabe K; Yoshida M; Takahashi S; Ohara H; Joh T
    J Hepatobiliary Pancreat Sci; 2011 Mar; 18(2):154-61. PubMed ID: 20740366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pediatric "PSC-IBD": a descriptive report of associated inflammatory bowel disease among pediatric patients with psc.
    Faubion WA; Loftus EV; Sandborn WJ; Freese DK; Perrault J
    J Pediatr Gastroenterol Nutr; 2001 Sep; 33(3):296-300. PubMed ID: 11593125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.